Ambulatory medicament pump with safe access control
AssigneeBeta Bionics, Inc.
InventorsMichael J. Rosinko, Edward R. Damiano, Himanshu Patel, Firas H. El-Khatib, Robert James LeBourdais
Life of this patent
Estimating the term…
Loading patent…
AssigneeBeta Bionics, Inc.
InventorsMichael J. Rosinko, Edward R. Damiano, Himanshu Patel, Firas H. El-Khatib, Robert James LeBourdais
Estimating the term…
Systems and methods are disclosed herein for managing access to therapy controls of an ambulatory medicament pump that provides therapy to a subject using safe access levels associated with the therapy controls. The therapy change controls may enable modification of the corresponding therapy control parameters. The disclosed systems and methods can determine the eligibility of a subject receiving therapy from the ambulatory medicament pump or a user of the ambulatory medicament pump, for a safe access level and provide access to the corresponding therapy change controls. The ambulatory medicament pump may provide access to the therapy change controls upon receiving an access signal. In some cases, the ambulatory medicament pump may receive a time-based passcode and provide access to the therapy change controls upon receiving a matching passcode from the user.
An electronic configuration device configured to modify or enable modification, at a glucose level control system, of a control algorithm based on a selected safe access level for a user of an ambulatory medicament pump controlled by the glucose level control system, the electronic configuration device comprising:
A computer-implemented method of modifying or enabling modification, at a glucose level control system, of a control algorithm based on a selected safe access level for a user of an ambulatory medicament pump controlled by the glucose level control system, the computer-implemented method comprising:
An electronic configuration device configured to modify or enable modification, at a glucose level control system, of a control algorithm based on a selected safe access level for a user of the glucose level control system, the electronic configuration device comprising:
Dependencies are inferred from the claim text.